BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10445021)

  • 1. Prosorba column for rheumatoid arthritis.
    Med Lett Drugs Ther; 1999 Jul; 41(1058):69-70. PubMed ID: 10445021
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized double-blind sham-controlled trial of the Prosorba column for treatment of refractory rheumatoid arthritis.
    Gendreau RM;
    Ther Apher; 2001 Apr; 5(2):79-83. PubMed ID: 11354303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prosorba column for treatment of refractory rheumatoid arthritis: a randomized, double-blind, sham-controlled trial.
    Felson DT; LaValley MP; Baldassare AR; Block JA; Caldwell JR; Cannon GW; Deal C; Evans S; Fleischmann R; Gendreau RM; Harris ER; Matteson EL; Roth SH; Schumacher HR; Weisman MH; Furst DE
    Arthritis Rheum; 1999 Oct; 42(10):2153-9. PubMed ID: 10524687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical improvement in a patient with severe rheumatoid arthritis and chronic hepatitis B after prosorba column immunoadsorption: a one-year followup.
    Mugnier B; Poullin P; Lefevre P; Roudier J
    Arthritis Rheum; 2003 Oct; 49(5):722-3. PubMed ID: 14558061
    [No Abstract]   [Full Text] [Related]  

  • 5. [Plasmapheresis by adsorption. b. Immunoadsorption].
    Yamazaki Z; Fuzimori Y; Takahama T; Yoshizawa H; Takahashi K; Ogino T; Yamawaki N; Inagaki K; Tsuda N
    Nihon Rinsho; 1984 Aug; 42(8):1784-95. PubMed ID: 6392604
    [No Abstract]   [Full Text] [Related]  

  • 6. Protein A-immunoadsorption (Prosorba column) in the treatment of rheumatoid arthritis.
    Poullin P; Announ N; Mugnier B; Guis S; Roudier J; Lefèvre P
    Joint Bone Spine; 2005 Mar; 72(2):101-3. PubMed ID: 15797486
    [No Abstract]   [Full Text] [Related]  

  • 7. Vasculitis secondary to staphylococcal Protein A immunoadsorption (Prosorba column) treatment in rheumatoid arthritis.
    Deodhar A; Allen E; Daoud K; Wahba I
    Semin Arthritis Rheum; 2002 Aug; 32(1):3-9. PubMed ID: 12219317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rheumatoid arthritis].
    Kempe K; Tsuda H
    Nihon Rinsho; 2004 May; 62 Suppl 5():563-7. PubMed ID: 15197985
    [No Abstract]   [Full Text] [Related]  

  • 9. IL-1 trap go-ahead.
    Ratner M
    Nat Biotechnol; 2008 May; 26(5):485. PubMed ID: 18464767
    [No Abstract]   [Full Text] [Related]  

  • 10. Mononuclear cell (MC) functions by cryofiltration (CF) in rheumatoid arthritis (RA).
    Naganuma S; Suzuki T; Dustoor MM; Goldcamp JB; Amano K; Yamashita M; Omokawa S; Koo AP; Malchesky PS; Clough JD
    Prog Clin Biol Res; 1990; 337():495-8. PubMed ID: 2191339
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunoglobulin binding properties of the Prosorba immunadsorption column in treatment of rheumatoid arthritis.
    Sasso EH; Merrill C; Furst TE
    Ther Apher; 2001 Apr; 5(2):84-91. PubMed ID: 11354304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory inflames Centocor's profits.
    Glaser V
    Nat Biotechnol; 1998 Oct; 16(10):900. PubMed ID: 9788334
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lymphocytopheresis and plasmapheresis in rheumatoid arthritis].
    Dubrovina NA; Kalinin NN; Khotinian RI; Molchanova NP; Petrov MM
    Revmatologiia (Mosk); 1984; (3):9-12. PubMed ID: 6390635
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasmapheresis therapy in rheumatoid arthritis in Indian patients.
    Srivastava R; Vishwakarma GK; Tyagi S; Shukla RP; Das S; Bhandari RS
    J Assoc Physicians India; 1987 Feb; 35(2):133-5. PubMed ID: 3320018
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical efficiency of various intermittent plasmapheresis regimens in patients with rheumatoid arthritis (according to data of two clinics].
    Borisova AM; Siuniakova EV; Smirov VV; Denisenko BA
    Ter Arkh; 1989; 61(6):82-5. PubMed ID: 2799723
    [No Abstract]   [Full Text] [Related]  

  • 16. New COX-2 arthritis drug receives FDA approval.
    J Gend Specif Med; 2002; 5(2):6. PubMed ID: 11974679
    [No Abstract]   [Full Text] [Related]  

  • 17. Monoclonal antibodies: production, uses and side effects.
    Cowden J; Parker SK
    Pediatr Infect Dis J; 2006 Jun; 25(6):553-5. PubMed ID: 16732156
    [No Abstract]   [Full Text] [Related]  

  • 18. Issues in therapeutic apheresis.
    Berkman E
    N Engl J Med; 1982 Jun; 306(23):1418-20. PubMed ID: 6804867
    [No Abstract]   [Full Text] [Related]  

  • 19. How many types of patients meet classification criteria?
    Roth SH
    J Rheumatol; 1995 Jul; 22(7):1435; author reply 1435-6. PubMed ID: 7562792
    [No Abstract]   [Full Text] [Related]  

  • 20. How pharmacogenomics will impact the federal regulation of clinical trials and the new drug approval process.
    Binzak BA
    Food Drug Law J; 2003; 58(1):103-27. PubMed ID: 12739592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.